Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

Sofia Casares*, Kayo Inaba, Teodor Doru Brumeanu, Ralph M. Steinman, Constantin A. Bona

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

276 Scopus citations

Abstract

Intramuscular and intracutaneous immunization with naked DNA can vaccinate animals to the encoded proteins, but the underlying mechanisms of antigen presentation are unclear. We used DNA that encodes an A/PR/8/34 influenza peptide for CD4 T cells and that elicits protective antiviral immunity. DNA-transfected, cultured muscle cells released the influenza polypeptide, which then could be presented on the major histocompatibility complex class II molecules of dendritic cells. When DNA was injected into muscles or skin, and antigen-presenting cells were isolated from either the draining lymph nodes or the skin, dendritic, but not B, cells presented antigen to T cells and carried plasmid DNA. We suggest that the uptake of DNA and/or the protein expressed by dendritic cells triggers immune responses to DNA vaccines.

Original languageEnglish
Pages (from-to)1481-1486
Number of pages6
JournalJournal of Experimental Medicine
Volume186
Issue number9
DOIs
StatePublished - 3 Nov 1997
Externally publishedYes

Fingerprint

Dive into the research topics of 'Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope'. Together they form a unique fingerprint.

Cite this